Physician profile
Derek Johnson
NPI 1043625999
$3,719.61
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,168 · 2020: $582 · 2021: $970.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $888.83 | 2019-2021 | |
| Allergan, INC. | $679.60 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $318.75 | 2019 | |
| Eisai INC. | $314.57 | 2020-2021 | |
| Lundbeck LLC | $268.91 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $254.36 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $224.50 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $170.08 | 2019-2021 | |
| Adlon Therapeutics L.P. | $162.17 | 2019-2021 | |
| Bausch Health US, LLC | $142.80 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $128.63 | 2021 | |
| Abbvie INC. | $75.25 | 2021 | |
| Janssen Pharmaceuticals, INC | $42.58 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $21.56 | 2020 | |
| Avanir Pharmaceuticals, INC. | $13.85 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $13.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.